Physician profile
Bruce L Ring
NPI 1427043678
$2,328.71
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $995 · 2020: $874 · 2021: $460.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $744.46 | 2019-2021 | |
| Abbvie INC. | $405.57 | 2019-2021 | |
| Lilly USA, LLC | $289.99 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $137.75 | 2019-2021 | |
| Novo Nordisk INC | $116.91 | 2019-2020 | |
| Glaxosmithkline, LLC. | $104.42 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.22 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $82.21 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $66.30 | 2019-2020 | |
| Sanofi Pasteur INC. | $42.46 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $38.23 | 2019-2020 | |
| Amarin Pharma, INC. | $35.18 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $22.27 | 2019 | |
| Melinta Therapeutics, LLC | $20.66 | 2019 | |
| Sunovion Pharmaceuticals INC. | $20.64 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $20.01 | 2020 | |
| Janssen Pharmaceuticals, INC | $18.72 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.54 | 2019 | |
| Pfizer INC. | $16.43 | 2019 | |
| Abbott Laboratories | $15.27 | 2019 | |
| Hikma Pharmaceuticals USA | $13.33 | 2019 | |
| Dynavax Technologies Corporation | $9.14 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Ring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.